Every comorbidity related to diabetes causes life expectancy to plummet and medical costs to soar.
Read More »Using Dapagliflozin for Reduction in Adverse Renal and CV Outcomes
Patients had significant reduction in urinary albumin-to-creatinine ratio (UACR) in the first six months of using dapagliflozin.
Read More »Don’t Forget our Patients with Type 1 Diabetes
Cardiovascular and renal disease burdens also occur in type 1 diabetes.
Read More »ADA 81st Symposium: Evidence-Based Guidelines For Diabetes and Chronic Kidney Disease
Diabetes is the leading cause of chronic kidney disease due to microvascular damage to the renal blood vessels.
Read More »ADA 2021: Finerenone in the Chronic Kidney Disease and Diabetes Population
Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?
Read More »ADA 81st Symposium: Cardiovascular and Kidney Outcomes in Efpeglenatide
With the introduction of this glucagon-like peptide-1 receptor agonist (GLP-1 RA), efpeglenatide, could we see new cardiovascular and renal benefits for patients with type 2 diabetes?
Read More »Cardiovascular and Kidney Outcomes when Discontinuing SGLT-2 Inhibitor
After starting SGLT-2i, is the discontinuation of therapy necessary if there is an immediate decline in estimated Glomerular Filtration Rate (eGFR) in patients?
Read More »Renoprotective Effects of Metformin
Metformin, used in the management of blood glucose, may provide a renoprotective effect through inhibition of inflammation and apoptosis.
Read More »Treating Kidney Disease With Dapagliflozin
Researchers discovered that dapagliflozin helped patients with and without diabetes in improving kidney disease.
Read More »The Effect Of COVID-19 on Children with Type 1 Diabetes
Study found children with a new diagnosis of type 1 diabetes experienced higher rates of diabetic ketoacidosis in the COVID-19 pandemic.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.